Cargando…

Circulating cell-free DNA in serum as a biomarker for diagnosis and prognostic prediction of colorectal cancer

BACKGROUND: To verify whether the concentrations and integrity index of circulating cell-free DNA (ccf-DNA) in serum may be clinically useful for the diagnosis and progression monitoring of colorectal cancer (CRC) patients. METHODS: Serum samples were collected from 104 with primary CRC, 85 with ope...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hao, T B, Shi, W, Shen, X J, Qi, J, Wu, X H, Wu, Y, Tang, Y Y, Ju, S Q
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2014
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4200099/ https://www.ncbi.nlm.nih.gov/pubmed/25157833 http://dx.doi.org/10.1038/bjc.2014.470

Ejemplares similares

Serum microRNA panel as biomarkers for early diagnosis of colorectal adenocarcinoma
por: Zheng, G, et al.
Publicado: (2014)

Liquid biopsy by combining 5-hydroxymethylcytosine signatures of plasma cell-free DNA and protein biomarkers for diagnosis and prognosis of hepatocellular carcinoma
por: Cai, Z., et al.
Publicado: (2021)

Circulating lncRNA DANCR as a potential auxillary biomarker for the diagnosis and prognostic prediction of colorectal cancer
por: Shen, Xianjuan, et al.
Publicado: (2020)

Comparison of carcinoembryonic antigen prognostic value in serum and tumour tissue of patients with colorectal cancer
por: Li, M, et al.
Publicado: (2009)

The dynamic change of circulating tumour cells in patients with operable breast cancer before and after chemotherapy based on a multimarker QPCR platform
por: Chong, M-h, et al.
Publicado: (2012)

Serum circulating cell free DNA as potential diagnostic and prognostic biomarker in non small cell lung cancer
por: Soliman, Shimaa El-Shafey, et al.
Publicado: (2018)

Phosphoglycerate kinase-1 is a predictor of poor survival and a novel prognostic biomarker of chemoresistance to paclitaxel treatment in breast cancer
por: Sun, S, et al.
Publicado: (2015)

The impact of plasma epstein–barr virus DNA and fibrinogen on nasopharyngeal carcinoma prognosis: an observational study
por: Tang, L-Q, et al.
Publicado: (2014)

Admission Circulating Cell-Free DNA Levels as a Prognostic Factor in Pediatric Burns
por: Halpern, D., et al.
Publicado: (2022)

Epithelial–mesenchymal transition biomarkers and support vector machine guided model in preoperatively predicting regional lymph node metastasis for rectal cancer
por: Fan, X-J, et al.
Publicado: (2012)

Circulating Free DNA as Biomarker and Source for Mutation Detection in Metastatic Colorectal Cancer
por: Spindler, Karen Lise Garm, et al.
Publicado: (2015)

Cell-free circulating tumor RNAs in plasma as the potential prognostic biomarkers in colorectal cancer
por: Jin, Nana, et al.
Publicado: (2023)

Circulating Cell-Free DNA as a Prognostic Biomarker in Resectable Ampullary Cancer
por: Shyr, Bor-Uei, et al.
Publicado: (2021)

Prognostic implication of mucinous histology in colorectal cancer patients treated with adjuvant FOLFOX chemotherapy
por: Lee, D-W, et al.
Publicado: (2013)

Diagnostic and prognostic implications of serum miR-101 in osteosarcoma
por: Yao, Z.-S., et al.
Publicado: (2018)

Serum microRNA-210 as a potential noninvasive biomarker for the diagnosis and prognosis of glioma
por: Lai, N-s, et al.
Publicado: (2015)

The Prognostic Value of Circulating Cell-Free DNA in Colorectal Cancer: A Meta-Analysis
por: Basnet, Shiva, et al.
Publicado: (2016)

Methylated circulating tumor DNA as a biomarker for colorectal cancer diagnosis, prognosis, and prediction
por: Nassar, Farah J., et al.
Publicado: (2021)

Role of circulating free DNA in colorectal cancer
por: Matikas, Alexios, et al.
Publicado: (2016)

Abnormal DNA methylation as a cell-free circulating DNA biomarker for colorectal cancer detection: A review of literature
por: Galanopoulos, Michail, et al.
Publicado: (2017)

Clinical value evaluation of serum markers for early diagnosis of colorectal cancer
por: Song, Wen-Yue, et al.
Publicado: (2020)

Circulating tumour cells detected by a novel adenovirus-mediated system may be a potent therapeutic marker in gynaecological cancers
por: Takakura, M, et al.
Publicado: (2012)

Prognostic circulating proteomic biomarkers in colorectal liver metastases
por: Kim, Dongchan, et al.
Publicado: (2023)

Different primers for diagnosing circulating cell-free DNA of colorectal cancer
por: Shi, Hao, et al.
Publicado: (2020)

Real-world circulating tumor DNA analysis depicts resistance mechanism and clonal evolution in ALK inhibitor-treated lung adenocarcinoma patients
por: Hua, G., et al.
Publicado: (2022)

Prognostic model for survival of local recurrent nasopharyngeal carcinoma with intensity-modulated radiotherapy
por: Tian, Y-M, et al.
Publicado: (2014)

Circulating Cell Free DNA in the Diagnosis of Trophoblastic Tumors
por: Openshaw, Mark R., et al.
Publicado: (2015)

Genome-wide discovery of circulating cell-free DNA methylation biomarkers for colorectal cancer detection
por: Fang, Qingxiao, et al.
Publicado: (2023)

A serum-circulating long noncoding RNA signature can discriminate between patients with clear cell renal cell carcinoma and healthy controls
por: Wu, Y, et al.
Publicado: (2016)

Prognostic value of magnetic resonance imaging-detected cranial nerve invasion in nasopharyngeal carcinoma
por: Liu, X, et al.
Publicado: (2014)

Detection of Circulating Tumor DNA Methylation in Diagnosis of Colorectal Cancer
por: Xu, Fei, et al.
Publicado: (2021)

Accurate diagnosis of colorectal cancer based on histopathology images using artificial intelligence
por: Wang, K. S., et al.
Publicado: (2021)

Plasma Circulating Cell-free DNA Integrity as a Promising Biomarker for Diagnosis and Surveillance in Patients with Hepatocellular Carcinoma
por: Huang, Ao, et al.
Publicado: (2016)

Comparisons of vaginal and abdominal radical trachelectomy for early-stage cervical cancer: preliminary results of a multi-center research in China
por: Cao, D Y, et al.
Publicado: (2013)

Prognostic impact of histological categorisation of epithelial–mesenchymal transition in colorectal cancer
por: Ueno, H, et al.
Publicado: (2014)

Serum biomarker panels for the diagnosis of gastric adenocarcinoma
por: Ahn, H S, et al.
Publicado: (2012)

Severe obesity prior to diagnosis limits survival in colorectal cancer patients evaluated at a large cancer centre
por: Daniel, C R, et al.
Publicado: (2016)

Prognostic/predictive value of 207 serum factors in colorectal cancer treated with cediranib and/or chemotherapy
por: Spencer, S K M, et al.
Publicado: (2013)

LINE-1 hypomethylation status of circulating cell-free DNA in plasma as a biomarker for colorectal cancer
por: Nagai, Yuzo, et al.
Publicado: (2017)

Prognostic significance of Versican expression in gastric adenocarcinoma
por: Shen, X-H, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_v5m05mpddm6609p7khgt4ch301